1,4-Dioxane in Personal Care Products: The Byproduct Contaminant California's Prop 65 Keeps Catching

There’s no ingredient called “1,4-dioxane” on any cosmetic label. That’s the problem. It forms as an unwanted byproduct during the manufacturing of some of the most common surfactants and emulsifiers in personal care — the ones found in nearly every foaming shampoo, body wash, and facial cleanser on the market. California listed it as a carcinogen under Proposition 65 in 1988, and plaintiff-attorney enforcement actions have been a steady pressure on beauty brands ever since. A shampoo containing 10 ppm 1,4-dioxane, used at typical daily application rates, can generate a daily absorbed dose right at the state’s No Significant Risk Level (NSRL) of 30 µg/day. Brands that haven’t tested their finished products don’t know which side of that line they’re on.

What 1,4-Dioxane Is — And Why It Doesn’t Show Up on the Label

1,4-Dioxane is a cyclic ether, molecular formula C₄H₈O₂, that forms as a trace contaminant during ethoxylation — the industrial process that adds ethylene oxide units to fatty alcohols, fatty acids, or other compounds to produce water-soluble surfactants and emulsifiers. The reaction doesn’t proceed to 100% completion. Under certain temperature and pressure conditions, the ethylene oxide molecules cyclize to form 1,4-dioxane as a side reaction rather than incorporating into the desired polymer chain.

Because it’s a manufacturing artifact rather than an intentional ingredient, it doesn’t require disclosure on the ingredient list. Consumers have no visibility into its presence. And in practice, many brands don’t either — particularly smaller manufacturers that rely on supplier-provided certificates of analysis (COAs) for raw material clearance rather than testing the finished formulation.

The International Agency for Research on Cancer (IARC) classifies 1,4-dioxane as Group 2B, meaning possibly carcinogenic to humans. California’s Office of Environmental Health Hazard Assessment (OEHHA) added it to the Proposition 65 list in 1988 under the cancer endpoint. The NSRL — the daily exposure level below which no Prop 65 warning is required — is 30 micrograms per day. That number is the fulcrum around which finished-product compliance decisions get made.

Which Ingredients Create Contamination Risk

Not every personal care product carries 1,4-dioxane exposure. The risk is tied to specific manufacturing chemistry, and the ingredient list is usually a reliable early signal. Ingredients that warrant attention:

• Sodium laureth sulfate (SLES) — The most prevalent risk ingredient in this category. The “eth” in laureth signals ethoxylation. SLES is the primary surfactant in most shampoos, body washes, and foaming facial cleansers.
• PEG compounds — Polyethylene glycol derivatives appear across formulation types: PEG-4 and PEG-100 stearate in emulsions, PEG-150 distearate in shampoo thickeners. All are ethoxylation products.
• Polysorbates — Polysorbate 20, 60, and 80 are widely used emulsifiers in lotions, conditioners, and makeup. All are ethoxylated.
• Ceteareth and steareth compounds — Ceteareth-20 and steareth-2 appear regularly in hair care and skin moisturizers.
• “-oxynol” and “-eth” suffix ingredients — Any ingredient name ending in “-eth” or “-oxynol” is ethoxylated by definition.

Products with multiple ethoxylated ingredients in the same formula tend to carry higher measured 1,4-dioxane concentrations than single-surfactant products — though the relationship isn’t perfectly additive, since dioxane content varies significantly by supplier, manufacturing batch, and whether vacuum stripping was performed during production. That last point matters: vacuum stripping is a well-established post-processing step that can reduce 1,4-dioxane from 20–30 ppm down to sub-1 ppm levels. Some ingredient suppliers now sell specifically designated low-dioxane grades of SLES and PEG compounds, at price points comparable to standard grades, for brands that need documentation.

FDA has conducted multiple surveys of personal care products for 1,4-dioxane dating back to 1979. In more recent assessments, the agency has communicated that levels below approximately 10 ppm in rinse-off products present minimal cancer risk at typical usage levels — but this is not a regulatory limit, and FDA has not established a binding federal standard for 1,4-dioxane in cosmetics. California’s Prop 65 mechanism remains the primary enforcement pathway for brands selling in the state.

The Prop 65 Exposure Calculation — Where Compliance Gets Concrete

The Prop 65 NSRL of 30 µg/day doesn’t apply to product concentration directly. It applies to daily absorbed dose, which requires a usage-based exposure calculation using realistic application parameters.

The simplified formula:

Daily exposure (µg/day) = Product concentration (ppm) × Amount applied per use (g) × Frequency (uses/day) × Dermal absorption factor

Run this for a shampoo: 10 ppm 1,4-dioxane × 10 g applied per wash × 1 wash per day × 0.30 dermal absorption (a conservative factor for rinse-off products) = 30 µg/day. Exactly at the NSRL. That’s why 10 ppm has become the practical rule-of-thumb threshold for rinse-off products sold in California — not because any agency mandated it, but because the exposure math lands at the compliance boundary under reasonable conservative assumptions.

Leave-on products change the picture significantly. For a body lotion or facial moisturizer, dermal absorption factors are higher — typically in the 0.6–1.0 range depending on formulation and body site — and there’s no rinse-off dilution effect. At those parameters, 1,4-dioxane concentrations as low as 1–2 ppm can push daily exposures past 30 µg/day for products applied at generous amounts. Leave-on formulations containing PEG compounds or polysorbates warrant closer scrutiny and lower acceptable thresholds than their rinse-off counterparts.

This is precisely the math that plaintiff attorneys run when they send Prop 65 pre-litigation notices. We’ve seen brands blindsided by those letters because the supplier-provided COA either didn’t test for 1,4-dioxane at all, or tested only the bulk SLES ingredient in isolation rather than the finished formulation. Finished-product testing is the only defensible position in a Prop 65 context — because the dioxane content of your formulation isn’t the sum of your individual raw material levels. It’s a function of how those ingredients interact in the finished matrix, which batch of SLES your contract manufacturer sourced, and whether any thermal processing during production affected dioxane levels.

Other States Are Watching — And the Regulatory Pressure Is Building

California’s Prop 65 has been the dominant enforcement mechanism for personal care products, but the regulatory landscape is shifting elsewhere too. New York has enacted limits on 1,4-dioxane in household cleaning products, establishing a flat-ppm ceiling approach that doesn’t require the kind of exposure calculations Prop 65 demands. Other states are monitoring New York’s enforcement experience and weighing similar legislation.

The federal picture remains unchanged: FDA has not issued binding regulations on 1,4-dioxane in cosmetics, though the agency has consistently encouraged manufacturers to minimize contamination through in-process controls like vacuum stripping. What’s changed is market pressure. Retailer compliance programs, Amazon’s increasingly granular testing requirements for personal care SKUs, and the expansion of Prop 65 notice activity have collectively moved 1,4-dioxane from an “advanced testing” consideration to a baseline expectation for any California-distributed personal care brand.

Brands that distribute nationally — or that sell through major e-commerce channels — should assume their products will be scrutinized under the strictest applicable standard. In practice, that means designing a testing program that satisfies California’s Prop 65 exposure math.

How GC-MS Testing for 1,4-Dioxane Works — and What a Useful COA Actually Shows

1,4-Dioxane testing in finished personal care products is performed by gas chromatography-mass spectrometry (GC-MS). Headspace GC-MS is the preferred analytical approach for most rinse-off formulations: the sample is heated in a sealed vial, the volatile headspace is injected onto the GC column, and the MS detector identifies and quantifies the dioxane peak. Headspace extraction minimizes matrix interference from the surfactant-heavy base that would complicate direct-injection methods.

For high-viscosity or leave-on formulations — creams, butters, pomades — salting-out liquid-liquid extraction or solvent extraction prior to GC-MS analysis may be required to achieve adequate recovery. Method selection matters, and it should be documented on the COA.

Three numbers to evaluate when you receive a 1,4-dioxane COA:

1. Method detection limit (MDL): Should be ≤0.5 ppm to be meaningful for compliance work. A COA that reports “not detected” with an MDL of 5 ppm provides essentially no compliance protection — the product could contain 4.9 ppm and that result would still read as ND.

2. Limit of quantitation (LOQ): The lowest concentration at which the method gives a quantifiable result with defined accuracy and precision. For finished-product Prop 65 compliance purposes, an LOQ at or below 1 ppm is the right target for rinse-off products; sub-0.5 ppm is preferable for leave-on formulations.

3. Matrix validation documentation: The method should be validated in the specific product matrix — not just in solvent or water. Surfactant-heavy matrices like shampoos can cause ion suppression in the MS detector if gradient and temperature parameters aren’t optimized for the product type. An ISO 17025-accredited cosmetic testing laboratory will have validated their 1,4-dioxane methods across representative matrices and can provide supporting validation data on request.

One thing we see routinely in incoming samples: brands that test their flagship shampoo SKU but leave the rest of the line untested. If you have five shampoo formulations sharing the same base but using different fragrance systems or colorants, each needs independent testing. And any formulation change — even a seemingly minor one like switching to a different SLES supplier or adjusting surfactant concentration — can meaningfully shift 1,4-dioxane levels in the finished product. Batch-to-batch variability is real, particularly when manufacturers are sourcing SLES from multiple suppliers to manage raw material availability.

The Practical Path Forward for California Brands

If your personal care products distribute in California and contain any ethoxylated surfactant, the next move is straightforward. Test each finished-product SKU for 1,4-dioxane using a validated GC-MS method with an LOQ at or below 1 ppm, and obtain a COA from an ISO 17025-accredited cosmetic testing laboratory. If any product comes back above roughly 10 ppm for rinse-off or 2 ppm for leave-on applications, engage your formulator or ingredient supplier about reformulation options. Vacuum-stripped SLES and low-dioxane PEG grades are commercially available.

A Prop 65 pre-suit notice is expensive to defend even when you ultimately prevail — legal costs alone for a straightforward settlement routinely run into five figures. A routine 1,4-dioxane screen on a finished personal care product costs well under $200 per sample at an accredited lab. That math shouldn’t require much deliberation. The time to find out your product is at 12 ppm is before the plaintiff attorney finds it first.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• FDA Audit Preparedness for Cosmetic Manufacturers — Aurora TIC covers the regulatory consulting side of FDA cosmetic compliance, from 21 CFR documentation to audit readiness.
• Raw Material Supplier Qualification and COA Verification — Ayah Labs specializes in verifying raw material quality and COA accuracy for personal care and supplement ingredient sourcing.